{"id":120065,"date":"2026-11-17T19:06:03","date_gmt":"2026-11-17T16:06:03","guid":{"rendered":"https:\/\/prizrenpost.com\/al\/injeksioni-i-ri-kunder-obezitetit-humbje-peshe-deri-ne-254-cfare-zbuluan-shkencetaret\/"},"modified":"2026-11-17T19:06:03","modified_gmt":"2026-11-17T16:06:03","slug":"injeksioni-i-ri-kunder-obezitetit-humbje-peshe-deri-ne-254-cfare-zbuluan-shkencetaret","status":"publish","type":"post","link":"https:\/\/prizrenpost.com\/al\/injeksioni-i-ri-kunder-obezitetit-humbje-peshe-deri-ne-254-cfare-zbuluan-shkencetaret\/","title":{"rendered":"Injeksioni i ri kund\u00ebr obezitetit: Humbje peshe deri n\u00eb 25,4%, \u00e7far\u00eb zbuluan shkenc\u00ebtar\u00ebt?"},"content":{"rendered":"<figure class=\"post-featured-image\"><img decoding=\"async\" src=\"https:\/\/prizrenpost.com\/al\/wp-content\/uploads\/2026\/11\/17-7.jpg\" alt=\"Injeksioni i ri kund\u00ebr obezitetit: Humbje peshe deri n\u00eb 25,4%, \u00e7far\u00eb zbuluan shkenc\u00ebtar\u00ebt?\"\/><\/figure>\n<p>Rezultatet e fundit tregojn\u00eb se reagimi gjat\u00eb jav\u00ebve t\u00eb para mund t\u00eb ket\u00eb lidhje me suksesin e trajtimit<\/p>\n<p>Nj\u00eb ila\u00e7 eksperimental kund\u00ebr obezitetit ka regjistruar humbje mesatare t\u00eb pesh\u00ebs prej 25,4% te nj\u00eb grup pjes\u00ebmarr\u00ebsish n\u00eb nj\u00eb studim klinik, nd\u00ebrsa rezultatet e reja tregojn\u00eb se reagimi gjat\u00eb tet\u00eb jav\u00ebve t\u00eb para mund t\u00eb lidhet me suksesin e trajtimit n\u00eb afat m\u00eb t\u00eb gjat\u00eb.<\/p>\n<p>T\u00eb dh\u00ebnat u publikuan m\u00eb 15 n\u00ebntor 2026 nga kompania farmaceutike Novo Nordisk, gjat\u00eb konferenc\u00ebs shkencore ObesityWeek 2026, q\u00eb po mbahet n\u00eb Washington.<\/p>\n<p>N\u00eb qend\u00ebr t\u00eb v\u00ebmendjes \u00ebsht\u00eb CagriSema, nj\u00eb kombinim eksperimental i dy substancave aktive, cagrilintidit dhe semaglutidit, t\u00eb cilat veprojn\u00eb p\u00ebrmes mekanizmave t\u00eb ndrysh\u00ebm hormonal\u00eb p\u00ebr t\u00eb ndikuar n\u00eb oreks dhe ndjenj\u00ebn e ngopjes.<\/p>\n<p>Por risia m\u00eb interesante nuk lidhet vet\u00ebm me kilogram\u00ebt e humbur. Studiuesit kan\u00eb zbuluar se pjes\u00ebmarr\u00ebsit nuk reagojn\u00eb nj\u00ebsoj ndaj trajtimit dhe se ndryshimet mund t\u00eb v\u00ebrehen q\u00eb n\u00eb jav\u00ebt e para.<\/p>\n<p>\u00c7far\u00eb zbuluan shkenc\u00ebtar\u00ebt pas tet\u00eb jav\u00ebsh?<\/p>\n<p>Sipas rezultateve t\u00eb publikuara nga Novo Nordisk m\u00eb 15 n\u00ebntor, analiza e re e studimit t\u00eb faz\u00ebs s\u00eb tret\u00eb REDEFINE 1 tregoi se 67,8% e pjes\u00ebmarr\u00ebsve q\u00eb merrnin CagriSema kishin humbur t\u00eb pakt\u00ebn 5% t\u00eb pesh\u00ebs trupore brenda tet\u00eb jav\u00ebve t\u00eb para.<\/p>\n<p>K\u00ebta pjes\u00ebmarr\u00ebs u klasifikuan si persona me p\u00ebrgjigje t\u00eb hershme ndaj trajtimit.<\/p>\n<p>Pas 68 jav\u00ebsh, humbja mesatare e pesh\u00ebs n\u00eb k\u00ebt\u00eb grup arriti n\u00eb 25,4%, nd\u00ebrsa te pjes\u00ebmarr\u00ebsit q\u00eb reaguan m\u00eb ngadal\u00eb ishte 17,8%.<\/p>\n<p>P\u00ebr ta kuptuar m\u00eb leht\u00eb, nj\u00eb person q\u00eb fillon trajtimin me 100 kilogram\u00eb, n\u00ebse arrin humbje prej 25,4%, p\u00ebrfundon me rreth 74,6 kilogram\u00eb.<\/p>\n<p>Megjithat\u00eb, kjo p\u00ebrqindje nuk \u00ebsht\u00eb rezultati mesatar i t\u00eb gjith\u00eb personave t\u00eb trajtuar me CagriSema, por vet\u00ebm i grupit q\u00eb kishte reaguar m\u00eb shpejt, transmeton Telegrafi.<\/p>\n<p>Nga pjes\u00ebmarr\u00ebsit q\u00eb reaguan her\u00ebt, 73,3% arrit\u00ebn t\u00eb humbnin t\u00eb pakt\u00ebn 20% t\u00eb pesh\u00ebs fillestare deri n\u00eb jav\u00ebn e 68-t\u00eb.<\/p>\n<p>N\u00eb grupin q\u00eb reagoi m\u00eb ngadal\u00eb, k\u00ebt\u00eb nivel t\u00eb humbjes s\u00eb pesh\u00ebs e arrit\u00ebn 37,2% e pjes\u00ebmarr\u00ebsve.<\/p>\n<p>Kjo tregon nj\u00eb lidhje t\u00eb r\u00ebnd\u00ebsishme mes ritmit fillestar t\u00eb dob\u00ebsimit dhe rezultatit t\u00eb m\u00ebvonsh\u00ebm.<\/p>\n<p>Megjithat\u00eb, studiuesit theksojn\u00eb se analiza \u00ebsht\u00eb eksploruese. Ajo \u00ebsht\u00eb kryer pas p\u00ebrfundimit t\u00eb studimit kryesor dhe nuk provon se p\u00ebrgjigjja gjat\u00eb tet\u00eb jav\u00ebve t\u00eb para mund t\u00eb parashikoj\u00eb me siguri rezultatin individual t\u00eb pacientit.<\/p>\n<p>Jo vet\u00ebm dob\u00ebsim: P\u00ebrmir\u00ebsime edhe n\u00eb jet\u00ebn e p\u00ebrditshme<\/p>\n<p>Nj\u00eb tjet\u00ebr analiz\u00eb e prezantuar gjat\u00eb ObesityWeek 2026 ka vler\u00ebsuar ndikimin e CagriSema n\u00eb funksionimin fizik dhe mir\u00ebqenien psikologjike.<\/p>\n<p>Sipas t\u00eb dh\u00ebnave zyrtare t\u00eb studimit REDEFINE 1, 73,1% e pjes\u00ebmarr\u00ebsve q\u00eb merrnin CagriSema raportuan p\u00ebrmir\u00ebsime dometh\u00ebn\u00ebse n\u00eb funksionimin fizik, krahasuar me 49,1% n\u00eb grupin placebo.<\/p>\n<p>P\u00ebrmir\u00ebsimet kishin t\u00eb b\u00ebnin me aft\u00ebsin\u00eb p\u00ebr t\u00eb kryer aktivitetet e p\u00ebrditshme dhe kufizimet fizike t\u00eb lidhura me pesh\u00ebn.<\/p>\n<p>Edhe n\u00eb aspektin psikologjik u regjistruan rezultate t\u00eb r\u00ebnd\u00ebsishme: 69% e pjes\u00ebmarr\u00ebsve q\u00eb merrnin CagriSema raportuan p\u00ebrmir\u00ebsime dometh\u00ebn\u00ebse, kundrejt 42,1% t\u00eb atyre q\u00eb merrnin placebo.<\/p>\n<p>K\u00ebto t\u00eb dh\u00ebna sugjerojn\u00eb se p\u00ebrfitimet e mundshme nga trajtimi i obezitetit mund t\u00eb shkojn\u00eb p\u00ebrtej ndryshimit t\u00eb pesh\u00ebs trupore.<\/p>\n<p>A do t\u00eb thot\u00eb kjo se ila\u00e7i funksionon nj\u00ebsoj te t\u00eb gjith\u00eb?<\/p>\n<p>Jo. Pik\u00ebrisht dallimet mes pjes\u00ebmarr\u00ebsve p\u00ebrb\u00ebjn\u00eb nj\u00eb nga mesazhet m\u00eb t\u00eb r\u00ebnd\u00ebsishme t\u00eb analiz\u00ebs s\u00eb re.<\/p>\n<p>Nj\u00eb reagim m\u00eb i ngadalsh\u00ebm nuk n\u00ebnkupton domosdoshm\u00ebrisht munges\u00eb efekti. Edhe grupi q\u00eb nuk arriti t\u00eb humbte 5% t\u00eb pesh\u00ebs gjat\u00eb tet\u00eb jav\u00ebve t\u00eb para regjistroi humbje t\u00eb konsiderueshme pas 68 jav\u00ebsh.<\/p>\n<p>Gjithashtu, CagriSema mbetet trajtim eksperimental dhe ende nuk \u00ebsht\u00eb miratuar p\u00ebr p\u00ebrdorim t\u00eb zakonsh\u00ebm. Siguria, efektet an\u00ebsore dhe p\u00ebrfitimet afatgjata vazhdojn\u00eb t\u00eb jen\u00eb pjes\u00eb e vler\u00ebsimit klinik.<\/p>\n<p>\u00c7far\u00eb ndryshon pas rezultateve t\u00eb fundit?<\/p>\n<p>Zbulimi i prezantuar m\u00eb 15 n\u00ebntor hap nj\u00eb drejtim interesant n\u00eb trajtimin e obezitetit: kuptimin m\u00eb t\u00eb mir\u00eb t\u00eb m\u00ebnyr\u00ebs se si pacient\u00ebt reagojn\u00eb ndaj ila\u00e7eve dhe identifikimin e faktor\u00ebve q\u00eb lidhen me suksesin e trajtimit.<\/p>\n<p>Megjithat\u00eb, t\u00eb dh\u00ebnat e reja nuk jan\u00eb ende baz\u00eb p\u00ebr ndryshimin e vendimeve klinike vet\u00ebm sipas humbjes s\u00eb pesh\u00ebs n\u00eb jav\u00ebt e para.<\/p>\n<p>Rezultatet e ObesityWeek 2026 tregojn\u00eb se shkenca po p\u00ebrparon drejt trajtimeve gjithnj\u00eb e m\u00eb t\u00eb individualizuara, ku r\u00ebnd\u00ebsi ka jo vet\u00ebm sa pesh\u00eb humbet pacienti, por edhe si p\u00ebrmir\u00ebsohet sh\u00ebndeti dhe cil\u00ebsia e jet\u00ebs s\u00eb tij.<\/p>\n<hr style=\"margin:30px 0\"\/>\n<p style=\"font-size:13px;color:#666\">Burimi: <strong>mesazhi<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rezultatet e fundit tregojn\u00eb se reagimi gjat\u00eb jav\u00ebve t\u00eb para mund t\u00eb ket\u00eb lidhje me suksesin e trajtimit Nj\u00eb ila\u00e7 eksperimental kund\u00ebr obezitetit ka regjistruar humbje mesatare t\u00eb pesh\u00ebs prej 25,4% te nj\u00eb grup pjes\u00ebmarr\u00ebsish n\u00eb nj\u00eb studim klinik, nd\u00ebrsa rezultatet e reja tregojn\u00eb se reagimi gjat\u00eb tet\u00eb jav\u00ebve t\u00eb para mund t\u00eb lidhet me [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":120064,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-120065","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-shendetesi"],"_links":{"self":[{"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/posts\/120065","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/comments?post=120065"}],"version-history":[{"count":0,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/posts\/120065\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/media\/120064"}],"wp:attachment":[{"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/media?parent=120065"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/categories?post=120065"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prizrenpost.com\/al\/wp-json\/wp\/v2\/tags?post=120065"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}